Lv1
70 积分 2024-07-06 加入
LBA74 Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 1
6个月前
已完结
B-391 Is Comprehensive Cancer Panel By Next-generation Sequencing (NGS) More Efficient Than Cancer-specific NGS Panel in the Management of Non-small Cell Lung Cancer Patients?
7个月前
已完结
Concordance of next-generation sequencing between tissue and liquid biopsies in non-small cell lung cancer
7个月前
已关闭
Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers
7个月前
已完结
Feasibility using bronchoscopic specimens for next-generation sequencing in resectable non-small lung cancer
7个月前
已关闭
Recent advance of next-generation sequencing in patients with lung cancer
7个月前
已完结
Lung Adenocarcinoma Harboring Concomitant EGFR Mutation and EML4-ALK Fusion That Benefits From Three Kinds of Tyrosine Kinase Inhibitors: A Case Report and Literature Review
7个月前
已完结
Differential Responses to Targeted Therapies in Non-Small Cell Lung Cancer: A Comparative Analysis of Outcomes in Patients with Single EGFR Mutation and Concurrent Gene Alterations
7个月前
已完结
Dual-targeting therapeutic strategy for concurrent EGFR and ALK alterations in non-small-cell lung cancer: a case report and literature review
7个月前
已关闭
皖公网安备34019202002308
